The Impact of Current Opioid Agonist Therapy on Hepatitis C Virus Treatment Initiation Among People Who Use Drugs From the Direct-acting Antiviral (DAA) Era: A Population-Based Study

Abstract Background Evidence that opioid agonist therapy (OAT) is associated with increased odds of hepatitis C virus (HCV) treatment initiation among people who use drugs (PWUD) is emerging. The objective of this study was to determine the association between current OAT and HCV treatment initiatio...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical infectious diseases 2022-03, Vol.74 (4), p.575-583
Hauptverfasser:	Bartlett, Sofia R, Wong, Stanley, Yu, Amanda, Pearce, Margo, MacIsaac, Julia, Nouch, Susan, Adu, Prince, Wilton, James, Samji, Hasina, Clementi, Emilia, Velasquez, Hector, Jeong, Dahn, Binka, Mawuena, Alvarez, Maria, Wong, Jason, Buxton, Jane, Krajden, Mel, Janjua, Naveed Z
Format:	Artikel
Sprache:	eng
Schlagworte:	Analgesics, Opioid - therapeutic use Antiviral Agents - therapeutic use Hepacivirus Hepatitis C - complications Hepatitis C - drug therapy Hepatitis C - epidemiology Hepatitis C, Chronic - complications Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - epidemiology Humans Major and Commentaries Substance Abuse, Intravenous - complications
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!